Advertisement
Advertisement

TRIB

TRIB logo

Trinity Biotech plc

0.70
USD
+0.02
+2.35%
Aug 01, 15:36 UTC -4
Closed
exchange

After-Market

0.70

0.00
0.00%

Trinity Biotech plc Profile

Info & Links

CEO

John Gillard

Headquarters

IDA BUSINESS PARK, BRAY
WICKLOW, L2 A98 H5C8, IRELAND

Sector

Medical

Auditor

GRANT THORNTON

Share holders

--

Employees

401

Trinity Biotech plc Statistics

Valuation Measures

Market Capitalization2

13.08M

Enterprise Value

108.68M

Enterprise Value/EBITDA(ttm)

-5.63

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

34.88%

Operating Margin(ttm)

--

Profit Margin(ttm)

-50.89%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-49.71%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

61.55M

Revenue Per Share(ttm)

3.43

Gross Profit(ttm)

21.44M

EBITDA(ttm)3

-19.30M

Net Income Available to Common(ttm)

-31.79M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

-76.44%

S&P 500 52-Week Change

16.67%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

17.96M

Dividend Yield

--

Float4

--

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

5.17M

Total Cash Per Share(mrq)

0.29

Total Debt(mrq)

100.76M

Total Debt/Equity(mrq)

-286.42%

Current Ratio(mrq)

1.28%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

-1.89

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.23

Free Cash Flow(ytd)

-4.60M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement